187 related articles for article (PubMed ID: 9647347)
1. The molecular mobility of supercooled amorphous indomethacin as a function of temperature and relative humidity.
Andronis V; Zografi G
Pharm Res; 1998 Jun; 15(6):835-42. PubMed ID: 9647347
[TBL] [Abstract][Full Text] [Related]
2. Time-dependence of molecular mobility during structural relaxation and its impact on organic amorphous solids: an investigation based on a calorimetric approach.
Mao C; Chamarthy SP; Pinal R
Pharm Res; 2006 Aug; 23(8):1906-17. PubMed ID: 16858653
[TBL] [Abstract][Full Text] [Related]
3. Molecular mobility of supercooled amorphous indomethacin, determined by dynamic mechanical analysis.
Andronis V; Zografi G
Pharm Res; 1997 Apr; 14(4):410-4. PubMed ID: 9144723
[TBL] [Abstract][Full Text] [Related]
4. Solid-state characteristics of amorphous sodium indomethacin relative to its free acid.
Tong P; Zografi G
Pharm Res; 1999 Aug; 16(8):1186-92. PubMed ID: 10468018
[TBL] [Abstract][Full Text] [Related]
5. Molecular mobility of amorphous S-flurbiprofen: a dielectric relaxation spectroscopy approach.
Rodrigues AC; Viciosa MT; Danède F; Affouard F; Correia NT
Mol Pharm; 2014 Jan; 11(1):112-30. PubMed ID: 24215236
[TBL] [Abstract][Full Text] [Related]
6. Crystallization of indomethacin from the amorphous state below and above its glass transition temperature.
Yoshioka M; Hancock BC; Zografi G
J Pharm Sci; 1994 Dec; 83(12):1700-5. PubMed ID: 7891297
[TBL] [Abstract][Full Text] [Related]
7. Physical stability and relaxation of amorphous indomethacin.
Vyazovkin S; Dranca I
J Phys Chem B; 2005 Oct; 109(39):18637-44. PubMed ID: 16853398
[TBL] [Abstract][Full Text] [Related]
8. An investigation into the thermal behaviour of an amorphous drug using low frequency dielectric spectroscopy and modulated temperature differential scanning calorimetry.
He R; Craig DQ
J Pharm Pharmacol; 2001 Jan; 53(1):41-8. PubMed ID: 11206191
[TBL] [Abstract][Full Text] [Related]
9. Dielectric study of the molecular mobility and the isothermal crystallization kinetics of an amorphous pharmaceutical drug substance.
Alie J; Menegotto J; Cardon P; Duplaa H; Caron A; Lacabanne C; Bauer M
J Pharm Sci; 2004 Jan; 93(1):218-33. PubMed ID: 14648651
[TBL] [Abstract][Full Text] [Related]
10. Molecular mobility of amorphous pharmaceutical solids below their glass transition temperatures.
Hancock BC; Shamblin SL; Zografi G
Pharm Res; 1995 Jun; 12(6):799-806. PubMed ID: 7667182
[TBL] [Abstract][Full Text] [Related]
11. The activation energy at Tg and the fragility index of indomethacin, predicted from the influence of the heating rate on the temperature position and on the intensity of thermally stimulated depolarization current peak.
Ramos JJ; Correia NT; Taveira-Marques R; Collins G
Pharm Res; 2002 Dec; 19(12):1879-84. PubMed ID: 12523669
[TBL] [Abstract][Full Text] [Related]
12. Complementarity of mDSC, DMA, and DRS Techniques in the Study of
Thayumanasundaram S; Venkatesan TR; Ousset A; Van Hollebeke K; Aerts L; Wübbenhorst M; Van den Mooter G
Mol Pharm; 2022 Jul; 19(7):2299-2315. PubMed ID: 35674392
[TBL] [Abstract][Full Text] [Related]
13. Different measures of molecular mobility: comparison between calorimetric and thermally stimulated current relaxation times below Tg and correlation with dielectric relaxation times above Tg.
Bhugra C; Shmeis R; Krill SL; Pikal MJ
J Pharm Sci; 2008 Oct; 97(10):4498-515. PubMed ID: 18271035
[TBL] [Abstract][Full Text] [Related]
14. Enthalpy relaxation in binary amorphous mixtures containing sucrose.
Shamblin SL; Zografi G
Pharm Res; 1998 Dec; 15(12):1828-34. PubMed ID: 9892465
[TBL] [Abstract][Full Text] [Related]
15. The use of inverse phase gas chromatography to study the glass transition temperature of a powder surface.
Buckton G; Ambarkhane A; Pincott K
Pharm Res; 2004 Sep; 21(9):1554-7. PubMed ID: 15497678
[TBL] [Abstract][Full Text] [Related]
16. Calorimetric evidence for two distinct molecular packing arrangements in stable glasses of indomethacin.
Kearns KL; Swallen SF; Ediger MD; Sun Y; Yu L
J Phys Chem B; 2009 Feb; 113(6):1579-86. PubMed ID: 19154147
[TBL] [Abstract][Full Text] [Related]
17. Dipolar Reorientations in Amorphous Nimesulide: A TSDC and DSC Study.
Moura Ramos JJ; Diogo HP
Curr Drug Deliv; 2017; 14(1):91-98. PubMed ID: 27160253
[TBL] [Abstract][Full Text] [Related]
18. Determination of the viscosity of an amorphous drug using thermomechanical analysis (TMA).
Hancock BC; Dupuis Y; Thibert R
Pharm Res; 1999 May; 16(5):672-5. PubMed ID: 10350009
[TBL] [Abstract][Full Text] [Related]
19. Prediction of onset of crystallization from experimental relaxation times. II. Comparison between predicted and experimental onset times.
Bhugra C; Shmeis R; Krill SL; Pikal MJ
J Pharm Sci; 2008 Jan; 97(1):455-72. PubMed ID: 17854050
[TBL] [Abstract][Full Text] [Related]
20. Effect of molecular structure and water content on the dielectric relaxation behaviour of amorphous low molecular weight carbohydrates above and below their glass transition.
Noel TR; Parker R; Ring SG
Carbohydr Res; 2000 Dec; 329(4):839-45. PubMed ID: 11125826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
